Angela Talley
Chief Tech/Sci/R&D Officer en SPERO THERAPEUTICS, INC. .
Perfil
Angela Talley is currently working as the Senior Vice President of Clinical Development at Spero Therapeutics, Inc. She previously worked as the Executive Director of Clinical Development at Allergan Ltd.
Dr. Talley holds a doctorate degree from the Icahn School of Medicine at Mount Sinai.
Cargos activos de Angela Talley
| Empresas | Cargo | Inicio |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Angela Talley.
| Empresas | Cargo | Fin |
|---|---|---|
| ALLERGAN PLC | Corporate Officer/Principal | - |
Formación de Angela Talley.
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SPERO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Angela Talley
